Squarepoint Ops LLC - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 268 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 3.49 and the average weighting 0.1%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$830,050
+62.2%
20,715
+56.3%
0.00%
+50.0%
Q4 2022$511,660
-26.9%
13,252
+0.7%
0.00%
-50.0%
Q3 2022$700,000
-17.5%
13,166
-9.5%
0.00%
-20.0%
Q2 2022$848,000
-73.0%
14,543
-64.7%
0.01%
-61.5%
Q1 2022$3,145,000
+13.4%
41,206
-10.6%
0.01%
+85.7%
Q4 2021$2,773,000
-16.7%
46,092
-22.4%
0.01%
-30.0%
Q3 2021$3,327,000
+59.6%
59,419
+73.0%
0.01%
+25.0%
Q2 2021$2,085,000
+127.1%
34,355
+124.0%
0.01%
+14.3%
Q4 2020$918,000
-42.0%
15,336
-41.7%
0.01%
-66.7%
Q3 2020$1,582,000
+220.2%
26,321
+179.6%
0.02%
+162.5%
Q2 2020$494,000
-72.5%
9,415
-76.3%
0.01%
-27.3%
Q4 2019$1,796,000
+47.8%
39,656
+24.3%
0.01%0.0%
Q3 2019$1,215,000
-19.6%
31,905
-8.2%
0.01%
-26.7%
Q2 2019$1,511,000
-65.9%
34,740
-70.2%
0.02%
-68.1%
Q1 2019$4,436,000
+196.9%
116,550
+235.6%
0.05%
+176.5%
Q4 2018$1,494,000
+36.4%
34,728
+55.9%
0.02%
+30.8%
Q3 2018$1,095,000
+211.1%
22,278
+102.7%
0.01%
+160.0%
Q2 2018$352,000
-27.9%
10,989
+2.9%
0.01%
-44.4%
Q4 2017$488,000
-50.1%
10,680
-62.6%
0.01%
-86.2%
Q3 2016$978,000
+81.8%
28,592
+118.3%
0.06%
-51.5%
Q3 2015$538,00013,1000.13%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Gagnon Advisors, LLC 251,140$19,167,0008.83%
GAGNON SECURITIES LLC 610,933$46,626,0007.60%
Tamarack Advisers, LP 205,000$15,646,0007.40%
Spyglass Capital Management LLC 1,871,040$142,798,0004.88%
Lisanti Capital Growth, LLC 302,413$23,080,0002.59%
Rock Springs Capital Management LP 1,000,000$76,320,0001.92%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 208,197$15,890,0001.76%
JABODON PT CO 49,052$3,744,0001.70%
Zweig-DiMenna Associates LLC 166,675$12,721,0001.70%
NEUMEIER POMA INVESTMENT COUNSEL LLC 317,425$24,226,0001.63%
View complete list of PACIRA PHARMACEUTICALS INC shareholders